SynthesisBMJ open2022
Erlotinib plus bevacizumab versus erlotinib alone in patients with
Wusheng Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it
SynthesisBMJ open2022
Wusheng Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.